Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALHigh Alert

OVACE Plus

SULFACETAMIDE SODIUM

Standard Dose
DOSAGE AND ADMINISTRATION: Shake well before using. Apply to wet hair and massage vigorously into scalp. Rinse thoroughly. For best results, use at least twice a week or as directed by a doctor. Avoid contact with eyes or mucous membranes. Do not use on an infant less than 2 months of age.
Max Dose
See official label
Primary Use
INDICATIONS AND USAGE: This product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff).
Summary

Indications and usage INDICATIONS AND USAGE: This product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff).

Dosage and administration DOSAGE AND ADMINISTRATION: Shake well before using.

Structured Monograph

Clinical summary

Indications and usage INDICATIONS AND USAGE: This product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). Dosage and administration DOSAGE AND ADMINISTRATION: Shake well before using. Apply to wet hair and massage vigorously into scalp. Rinse thoroughly. For best results, use at least twice a week or as directed by a doctor. Avoid contact with eyes or mucous membranes. Do not use on an infant less than 2 months of age. Warnings and cautions WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP OUT OF THE REACH OF CHILDREN.

Monitoring

  • • WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals.
  • • Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically.
  • • Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported.
  • • In one of these cases, there was a fatal outcome.

Interaction Notes

  • • Review official label interaction section.